NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Falcon Vision

Falcon Vision

Menlo Park, Californiakkr.com

Overview

Falcon Vision is an ophthalmology-focused investment platform created and supported by KKR. The platform sources, evaluates, and provides operational and financial capabilities to a diversified portfolio of emerging ophthalmic medical device and biopharmaceutical companies. It collaborates with the team at Flying L Partners, led by industry veteran Dr. Bill Link, to identify and manage investment opportunities. The strategy is to address the need for capital and operational guidance to advance innovative products for under-managed ophthalmic diseases and vision preservation.

Portfolio Companies

6

Website

kkr.com

Investments

Falcon Vision investments
CompanyDateStageLead
ViaLaseApr 2024Series CLead
NewtonSep 2022Series CCo-investor
Aurion BiotechApr 2022Series CCo-investor
ViaLaseNov 2021Series BLead
TearClearAug 2020Series BLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMenlo Park, California
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.